CatSci Ltd, an award-winning innovation partner for medicines development, will be attending TIDES Europe 2023, a hybrid pharmaceutical event around oligonucleotides & peptides therapeutics. Hosted in Amsterdam, the TIDES meeting will take place on 30th October – 1st November 2023.
Dr Nigel Richardson, our Director of New Modalities, will be attending TIDES 2023. He is our expert in RNA Therapeutics. Nigel has decades of experience in the oligonucleotides space, having previously led GSK’s oligonucleotide therapy for Duchenne Muscular Dystrophy into the final stages of development and regulatory submission. Nigel leads our oligonucleotides function and was integral in opening our brand-new, state-of-the-art oligonucleotides laboratory earlier this year. Our 40+ years of collective experience combined with our state-of-the-art equipment and dedicated analytical support enable us to develop tailored solutions with speed and scientific integrity.
The TIDES conference will bring together a host of world-renowned experts across the entire landscape of oligonucleotides, peptides, mRNA, drug delivery and partnering strategies, from discovery to market. Nigel is looking forward to networking with the industry and engaging with like-minded experts. He is excited to discuss in-depth development strategies, trends and technologies across the entire oligonucleotide and peptide spectrum, as well as CatSci’s capabilities in advancing these complex molecules to accelerate the development of our customers’ RNA therapeutics.
To learn more about our oligonucleotide research, development, and manufacturing capabilities, listen to Dr Nigel Richardson here.